Clinical trial PM1183-B-005-14
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | PharmaMar |
EudraCT Identifier | 2014-003773-42 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02454972 |
Inclusion criteria | brca 1/2 |
Last update |